Iksan, South Korea

Hyun Kyoung Ko

This inventor holds 1 USPTO granted patent. Top assignees: Dong-A Pharmaceutical Co., Ltd, Yuhan Corporation. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyun Kyoung Ko. Retrieved from https://idiyas.com/inventor/hyun-kyoung-ko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyun Kyoung Ko: Innovator in Pharmaceutical Chemistry

Introduction

Hyun Kyoung Ko is a notable inventor based in Iksan, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential.

Latest Patents

One of her key patents is for "1-phenylpiperidin-3-one derivatives and processes for the preparation thereof." This patent includes the development of 1-phenylpiperidin-3-one derivatives and their pharmaceutically acceptable salts, which exhibit cysteine protease inhibitory activity. The patent also covers pharmaceutical compositions containing these derivatives as active ingredients, along with the processes for their preparation. Hyun Kyoung Ko holds 1 patent.

Career Highlights

Throughout her career, Hyun Kyoung Ko has worked with prominent companies in the pharmaceutical industry. She has been associated with Yuhan Corporation and Dong-A Pharmaceutical Co., Ltd. These experiences have allowed her to apply her innovative ideas in practical settings, contributing to advancements in drug development.

Collaborations

Hyun Kyoung Ko has collaborated with several professionals in her field, including Jong Wook Lee and Bong Yong Lee. These partnerships have fostered a collaborative environment that enhances research and innovation.

Conclusion

Hyun Kyoung Ko's work in pharmaceutical chemistry exemplifies the impact of innovation in developing new therapeutic agents. Her contributions continue to influence the field and inspire future research endeavors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…